Christopher M. Yea

2019

In 2019, Christopher M. Yea earned a total compensation of $1.4M as Chief Development Officer at Carbylan Therapeutics, a 73% increase compared to previous year.

Compensation breakdown

Bonus$174,596
Option Awards$891,350
Salary$341,093
Other$20,466
Total$1,427,505

Yea received $891.4K in option awards, accounting for 62% of the total pay in 2019.

Yea also received $174.6K in bonus, $341.1K in salary and $20.5K in other compensation.

Rankings

In 2019, Christopher M. Yea's compensation ranked 7,555th out of 13,971 executives tracked by ExecPay. In other words, Yea earned more than 45.9% of executives.

ClassificationRankingPercentile
All
7,555
out of 13,971
46th
Division
Manufacturing
2,940
out of 5,701
48th
Major group
Chemicals And Allied Products
1,108
out of 2,200
50th
Industry group
Drugs
944
out of 1,886
50th
Industry
Pharmaceutical Preparations
698
out of 1,398
50th
Source: SEC filing on August 25, 2020.

Yea's colleagues

We found three more compensation records of executives who worked with Christopher M. Yea at Carbylan Therapeutics in 2019.

2019

T Crockett

Carbylan Therapeutics

Chief Executive Officer

2019

Benjamin Palleiko

Carbylan Therapeutics

Chief Financial Officer

2019

Edward Feener

Carbylan Therapeutics

Chief Scientific Officer

News

In-depth

You may also like